ImmuneIntelligence International AB is a Swedish AB based in Lund, operating in the Business and other management consultancy activities sector. Incorporated in 2022, the company reported revenue of 1,9 mn kr in its latest annual filing.
Företaget ska bedriva konsultverksamhet inom företagsutveckling och företagsledning. Företaget ska bedriva konsultverksamhet inom medicinsk forskning, immunologi och tarmflora. Företaget ska bedriva handel med värdepapper inom en begränsad ägarkrets. Företaget ska bedriva fastighetsförvaltning och handel med fastigheter. Företaget ska importera livsmedel.
In its most recent annual report (2024), ImmuneIntelligence International AB reported revenue of 1,9 mn kr, a decrease of 29% on the year before. The figures on this page draw on 2 annual filings covering 2023 to 2024. The bottom line showed a net profit of 367,0 tn kr, and the EBITDA margin stood at 23.3%.
At the end of 2024, equity financed 51.2% of the balance sheet, and current assets covered short-term debt 1.9 times.
Frequently asked questions
What is the Org number of ImmuneIntelligence International AB?
ImmuneIntelligence International AB is registered with Bolagsverket / SCB under Org 5594012105.
What is the revenue of ImmuneIntelligence International AB?
ImmuneIntelligence International AB reported revenue of 1,9 mn kr in 2024.
Who is the CEO of ImmuneIntelligence International AB?
Shahram Aghaibeik-Lavasani is the CEO of ImmuneIntelligence International AB.
Where is ImmuneIntelligence International AB headquartered?
ImmuneIntelligence International AB's registered address is Scheelevägen 5 E Lgh 1106.
